# MGB · Device, Hemostasis, Vascular

_ ·  · Class 3_

**Canonical URL:** https://fda.innolitics.com/submissions/CV/CV-misc/MGB

## Overview

- **Product Code:** MGB
- **Device Name:** Device, Hemostasis, Vascular
- **Regulation:** 21 CFR N/A
- **Device Class:** 3
- **Review Panel:** [](/submissions/)

## Recent Cleared Devices (17 of 17)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [P210017](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P210017.md) | Cross-Seal Suture-Mediated Vascular Closure Device System | Terumo Medical Corporation | Sep 26, 2023 | APPR |
| [P180025](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P180025.md) | MANTA Vascular Closure Device | Teleflex Medical, LLC | Feb 1, 2019 | APPR |
| [P150006](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P150006.md) | CELT ACD VASCULAR CLOSURE DEVICE | Vasorum, Ltd. | Jul 20, 2016 | APPR |
| [P150022](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P150022.md) | CLOSER VASCULAR SEALING SYSTEM | Rex Medical, L.P. | Feb 12, 2016 | APPR |
| [P120016](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P120016.md) | VASCADE VASCULAR CLOSURE SYSTEM | Cardiva Medical, Inc. | Jan 31, 2013 | APPR |
| [P100013](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P100013.md) | CORDIS EXOSEAL VASCULAR CLOSURE DEVICE | Cordis US Corporation | May 19, 2011 | APPR |
| [P080029](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P080029.md) | QUICK-CLOSE VASCULAR SUTURING SYSTEM (QUICK-CLOSE SYSTEM) | Cardiva Medical, Inc. | Apr 8, 2010 | APWD |
| [P050043](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P050043.md) | FEMORAL INTRODUCER SHEATH AND HEMOSTASIS (FISH) DEVICE 5,6, AND 8 FRENCH | Morris Innovative Research, Inc. | Aug 20, 2007 | APPR |
| [P050007](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P050007.md) | STARCLOSE VASCULAR CLOSURE SYSTEM | Abbott Vascular Devices | Dec 21, 2005 | APPR |
| [P040044](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P040044.md) | MATRIX VASCULAR CLOSURE SYSTEM (VSG) | Cordis US Corporation | Aug 17, 2005 | APPR |
| [P040022](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P040022.md) | ANGIOLINK VASCULAR CLOSURE SYSTEM | Medtronic Vascular | Nov 3, 2004 | APWD |
| [P020035](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P020035.md) | X-PRESS 6 FRENCH VASCULAR CLOSURE SYSTEM | St. Jude Medical, Inc. | Sep 30, 2003 | APWD |
| [P010049](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P010049.md) | QUICKSEAL FEMORAL ARTERIAL CLOSURE SYSTEM | Sub-Q, Inc. | Mar 25, 2002 | APPR |
| [P990037](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P990037.md) | VASCULAR SOLUTIONS DUETT SEALING DEVICE | Vascular Solutions, Inc. | Jun 22, 2000 | APPR |
| [P960043](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P960043.md) | PROSTAR 9 FR. PERCUTANEOUS VASCULAR SURGICAL (PVS) SYSTEM | Abbott Vascular, Inc. | Apr 30, 1997 | APPR |
| [P930038](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P930038.md) | Angio Seal Vascular Closure Device | Terumo Medical Corporation | Sep 30, 1996 | APPR |
| [P920004](https://fda.innolitics.com/submissions/CV/CV-misc/MGB/P920004.md) | VASOSEAL (TM) | St. Jude Medical, Inc. | Sep 29, 1995 | APWD |

## Top Applicants

- Cardiva Medical, Inc. — 2 clearances
- Cordis US Corporation — 2 clearances
- St. Jude Medical, Inc. — 2 clearances
- Terumo Medical Corporation — 2 clearances
- Abbott Vascular Devices — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/CV/CV-misc/MGB](https://fda.innolitics.com/submissions/CV/CV-misc/MGB)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com